Matthew J. Brady to Rats, Wistar
This is a "connection" page, showing publications Matthew J. Brady has written about Rats, Wistar.
Connection Strength
0.143
-
The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levels. Biochim Biophys Acta. 2012 Jun; 1822(6):952-60.
Score: 0.100
-
Increased sensitivity of glycogen synthesis to phosphorylase-a and impaired expression of the glycogen-targeting protein R6 in hepatocytes from insulin-resistant Zucker fa/fa rats. FEBS J. 2006 May; 273(9):1989-99.
Score: 0.017
-
The glycogenic action of protein targeting to glycogen in hepatocytes involves multiple mechanisms including phosphorylase inactivation and glycogen synthase translocation. J Biol Chem. 2004 Nov 05; 279(45):46474-82.
Score: 0.015
-
Glycogen-targeting subunits and glucokinase differentially affect pathways of glycogen metabolism and their regulation in hepatocytes. J Biol Chem. 2002 Jan 11; 277(2):1514-23.
Score: 0.012